triamcinolone acetonide + anti-VEGF (CLS-1003) / Clearside Biomedical  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
triamcinolone acetonide + anti-VEGF (CLS-1003) / Clearside Biomedical
NCT02956330: Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201

Completed
N/A
20
US
Clearside Biomedical, Inc.
Macular Edema, Retinal Vein Occlusion
04/17
04/17

Download Options